| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |